The epidemiology, health and financial impacts of stimulant-associated heart failure with reduced ejection fraction (stimulant-HFrEF), specifically related to methamphetamine and cocaine use remains uncertain, as studies of patient-centered outcomes and… Click to show full abstract
The epidemiology, health and financial impacts of stimulant-associated heart failure with reduced ejection fraction (stimulant-HFrEF), specifically related to methamphetamine and cocaine use remains uncertain, as studies of patient-centered outcomes and health care resource utilization are lacking.
               
Click one of the above tabs to view related content.